Desfesoterodine is an active pharmaceutical ingredient (API) primarily used in medications for the treatment of overactive bladder (OAB) syndrome. It alleviates symptoms such as frequent urination, urgency, and urge incontinence by selectively antagonizing muscarinic receptors to relax bladder (detrusor) muscles. This increases bladder capacity, reduces contractions, and improves bladder control.

Offered at 99% purity, this specialty chemical is suitable for pharmaceutical research, drug synthesis, analytical reference standards, and development of OAB therapeutics.